vs
CECO ENVIRONMENTAL CORP（CECO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是CECO ENVIRONMENTAL CORP的1.0倍（$207.3M vs $205.9M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 16.5%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 22.4%）
CECO环保是1966年成立的美国工业技术企业，总部位于得克萨斯州达拉斯，在纳斯达克上市，股票代码为CECO。公司面向制造、化工、能源、炼油等工业领域，提供空气污染治理相关的技术、产品及服务，助力工业客户满足环保排放要求。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CECO vs RARE — 直观对比
营收规模更大
RARE
是对方的1.0倍
$205.9M
营收增速更快
RARE
高出9.4%
16.5%
两年增速更快
RARE
近两年复合增速
22.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.9M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | 31.0% | — |
| 营业利润率 | 0.9% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 16.5% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $0.98 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CECORARE
| Q1 26 | $205.9M | — | ||
| Q4 25 | $214.7M | $207.3M | ||
| Q3 25 | $197.6M | $159.9M | ||
| Q2 25 | $185.4M | $166.5M | ||
| Q1 25 | $176.7M | $139.3M | ||
| Q4 24 | $158.6M | $164.6M | ||
| Q3 24 | $135.5M | $139.5M | ||
| Q2 24 | $137.5M | $147.0M |
净利润CECORARE
| Q1 26 | — | — | ||
| Q4 25 | $3.1M | $-128.6M | ||
| Q3 25 | $1.5M | $-180.4M | ||
| Q2 25 | $9.5M | $-115.0M | ||
| Q1 25 | $36.0M | $-151.1M | ||
| Q4 24 | $4.9M | $-133.2M | ||
| Q3 24 | $2.1M | $-133.5M | ||
| Q2 24 | $4.5M | $-131.6M |
毛利率CECORARE
| Q1 26 | 31.0% | — | ||
| Q4 25 | 35.1% | — | ||
| Q3 25 | 32.7% | — | ||
| Q2 25 | 36.2% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 35.8% | — | ||
| Q3 24 | 33.4% | — | ||
| Q2 24 | 35.7% | — |
营业利润率CECORARE
| Q1 26 | 0.9% | — | ||
| Q4 25 | 7.7% | -54.7% | ||
| Q3 25 | 4.8% | -106.9% | ||
| Q2 25 | 9.7% | -64.8% | ||
| Q1 25 | 35.0% | -102.6% | ||
| Q4 24 | 7.1% | -74.3% | ||
| Q3 24 | 5.3% | -94.6% | ||
| Q2 24 | 6.7% | -79.1% |
净利率CECORARE
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | -62.0% | ||
| Q3 25 | 0.8% | -112.8% | ||
| Q2 25 | 5.1% | -69.0% | ||
| Q1 25 | 20.4% | -108.5% | ||
| Q4 24 | 3.1% | -80.9% | ||
| Q3 24 | 1.5% | -95.7% | ||
| Q2 24 | 3.3% | -89.5% |
每股收益（稀释后）CECORARE
| Q1 26 | $0.98 | — | ||
| Q4 25 | $0.09 | $-1.28 | ||
| Q3 25 | $0.04 | $-1.81 | ||
| Q2 25 | $0.26 | $-1.17 | ||
| Q1 25 | $0.98 | $-1.57 | ||
| Q4 24 | $0.14 | $-1.34 | ||
| Q3 24 | $0.06 | $-1.40 | ||
| Q2 24 | $0.12 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $45.4M | $421.0M |
| 总债务越低越好 | $5.3M | — |
| 股东权益账面价值 | $317.2M | $-80.0M |
| 总资产 | $1.0B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.02× | — |
8季度趋势，按日历期对齐
现金及短期投资CECORARE
| Q1 26 | $45.4M | — | ||
| Q4 25 | $33.1M | $421.0M | ||
| Q3 25 | $32.8M | $202.5M | ||
| Q2 25 | $36.8M | $176.3M | ||
| Q1 25 | $146.5M | $127.1M | ||
| Q4 24 | $37.8M | $174.0M | ||
| Q3 24 | $38.7M | $150.6M | ||
| Q2 24 | $36.5M | $480.7M |
总债务CECORARE
| Q1 26 | $5.3M | — | ||
| Q4 25 | $212.4M | — | ||
| Q3 25 | $220.9M | — | ||
| Q2 25 | $238.7M | — | ||
| Q1 25 | $339.7M | — | ||
| Q4 24 | $218.9M | — | ||
| Q3 24 | $133.4M | — | ||
| Q2 24 | $130.8M | — |
股东权益CECORARE
| Q1 26 | $317.2M | — | ||
| Q4 25 | $317.5M | $-80.0M | ||
| Q3 25 | $309.2M | $9.2M | ||
| Q2 25 | $298.4M | $151.3M | ||
| Q1 25 | $285.8M | $144.2M | ||
| Q4 24 | $247.7M | $255.0M | ||
| Q3 24 | $241.3M | $346.8M | ||
| Q2 24 | $235.0M | $432.4M |
总资产CECORARE
| Q1 26 | $1.0B | — | ||
| Q4 25 | $893.8M | $1.5B | ||
| Q3 25 | $891.9M | $1.2B | ||
| Q2 25 | $876.6M | $1.3B | ||
| Q1 25 | $957.1M | $1.3B | ||
| Q4 24 | $759.7M | $1.5B | ||
| Q3 24 | $621.5M | $1.5B | ||
| Q2 24 | $598.1M | $1.6B |
负债/权益比CECORARE
| Q1 26 | 0.02× | — | ||
| Q4 25 | 0.67× | — | ||
| Q3 25 | 0.71× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.55× | — | ||
| Q2 24 | 0.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流CECORARE
| Q1 26 | — | — | ||
| Q4 25 | $10.0M | $-99.8M | ||
| Q3 25 | $15.3M | $-91.4M | ||
| Q2 25 | $-7.7M | $-108.3M | ||
| Q1 25 | $-11.7M | $-166.5M | ||
| Q4 24 | $1.8M | $-79.3M | ||
| Q3 24 | $15.1M | $-67.0M | ||
| Q2 24 | $6.7M | $-77.0M |
自由现金流CECORARE
| Q1 26 | — | — | ||
| Q4 25 | $7.3M | $-100.8M | ||
| Q3 25 | $11.0M | $-92.7M | ||
| Q2 25 | $-8.7M | $-110.7M | ||
| Q1 25 | $-15.1M | $-167.8M | ||
| Q4 24 | $-4.3M | $-79.5M | ||
| Q3 24 | $11.1M | $-68.6M | ||
| Q2 24 | $2.5M | $-79.0M |
自由现金流率CECORARE
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | -48.6% | ||
| Q3 25 | 5.6% | -58.0% | ||
| Q2 25 | -4.7% | -66.5% | ||
| Q1 25 | -8.5% | -120.5% | ||
| Q4 24 | -2.7% | -48.3% | ||
| Q3 24 | 8.2% | -49.2% | ||
| Q2 24 | 1.9% | -53.7% |
资本支出强度CECORARE
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 0.5% | ||
| Q3 25 | 2.1% | 0.8% | ||
| Q2 25 | 0.6% | 1.5% | ||
| Q1 25 | 1.9% | 1.0% | ||
| Q4 24 | 3.9% | 0.1% | ||
| Q3 24 | 3.0% | 1.2% | ||
| Q2 24 | 3.0% | 1.4% |
现金转化率CECORARE
| Q1 26 | — | — | ||
| Q4 25 | 3.26× | — | ||
| Q3 25 | 10.18× | — | ||
| Q2 25 | -0.81× | — | ||
| Q1 25 | -0.33× | — | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | 7.24× | — | ||
| Q2 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CECO
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
